128 related articles for article (PubMed ID: 10211539)
1. Pharmacokinetic interaction of sparfloxacin and digoxin.
Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
[TBL] [Abstract][Full Text] [Related]
2. Effect of enrofloxacin on digoxin clearance and steady-state serum concentrations in dogs.
Novotny MJ; Shaw DH
Can J Vet Res; 1991 Apr; 55(2):113-6. PubMed ID: 1884291
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral cibenzoline on steady-state digoxin concentrations in healthy volunteers.
Khoo KC; Givens SV; Parsonnet M; Massarella JW
J Clin Pharmacol; 1988 Jan; 28(1):29-35. PubMed ID: 3350991
[TBL] [Abstract][Full Text] [Related]
4. Digoxin pharmacokinetics and spirapril, a new ace inhibitor.
Johnson BF; Wilson J; Johnson J; Flemming J
J Clin Pharmacol; 1991 Jun; 31(6):527-30. PubMed ID: 1880218
[TBL] [Abstract][Full Text] [Related]
5. Lack of pharmacokinetic interactions between moxonidine and digoxin.
Pabst G; Weimann HJ; Weber W
Clin Pharmacokinet; 1992 Dec; 23(6):477-81. PubMed ID: 1458765
[TBL] [Abstract][Full Text] [Related]
6. Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin.
Kamberi M; Tsutsumi K; Kotegawa T; Kawano K; Nakamura K; Niki Y; Nakano S
Antimicrob Agents Chemother; 1999 Mar; 43(3):525-9. PubMed ID: 10049262
[TBL] [Abstract][Full Text] [Related]
7. Lack of interaction between lomefloxacin and caffeine in normal volunteers.
Healy DP; Schoenle JR; Stotka J; Polk RE
Antimicrob Agents Chemother; 1991 Apr; 35(4):660-4. PubMed ID: 2069371
[TBL] [Abstract][Full Text] [Related]
8. Effect of temafloxacin on the pharmacokinetics of theophylline.
Ruff F; Santais MC; Callens E; Chauvin JP; Hazebroucq J
Am J Med; 1991 Dec; 91(6A):76S-80S. PubMed ID: 1662899
[TBL] [Abstract][Full Text] [Related]
9. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
Mant TG
Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
[TBL] [Abstract][Full Text] [Related]
10. Multiple-dose pharmacokinetics and safety of oral amifloxacin in healthy volunteers.
Cook JA; Silverman MH; Schelling DJ; Nix DE; Schentag JJ; Brown RR; Stroshane RM
Antimicrob Agents Chemother; 1990 Jun; 34(6):974-9. PubMed ID: 2393295
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol increases the systemic bioavailability of oral digoxin.
De Mey C; Brendel E; Enterling D
Br J Clin Pharmacol; 1990 Apr; 29(4):486-90. PubMed ID: 1970265
[TBL] [Abstract][Full Text] [Related]
12. Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals.
Kirch W; Logemann C; Heidemann H; Santos SR; Ohnhaus EE
Eur J Clin Pharmacol; 1986; 31(4):391-5. PubMed ID: 3816917
[TBL] [Abstract][Full Text] [Related]
13. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.
Oosterhuis B; Jonkman JH; Andersson T; Zuiderwijk PB; Jedema JN
Br J Clin Pharmacol; 1991 Nov; 32(5):569-72. PubMed ID: 1954072
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the potential pharmacokinetic interaction between digoxin and ethmozine.
MacFarland RT; Moeller VR; Pieniaszek HJ; Whitney CC; Marcus FI
J Clin Pharmacol; 1985 Mar; 25(2):138-43. PubMed ID: 3886709
[TBL] [Abstract][Full Text] [Related]
15. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
Lefebvre RA; Bogaert MG; Duprez D
Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206
[TBL] [Abstract][Full Text] [Related]
16. Effect of a new quinolone, sparfloxacin, on the pharmacokinetics of theophylline in asthmatic patients.
Takagi K; Yamaki K; Nadai M; Kuzuya T; Hasegawa T
Antimicrob Agents Chemother; 1991 Jun; 35(6):1137-41. PubMed ID: 1929255
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of digoxin and main metabolites/derivatives in healthy humans.
Hinderling PH; Hartmann D
Ther Drug Monit; 1991 Sep; 13(5):381-401. PubMed ID: 1957331
[TBL] [Abstract][Full Text] [Related]
18. Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
Kisicki JC; Griess RS; Ott CL; Cohen GM; McCormack RJ; Troetel WM; Imbimbo BP
Antimicrob Agents Chemother; 1992 Jun; 36(6):1296-301. PubMed ID: 1329618
[TBL] [Abstract][Full Text] [Related]
19. Effects of amlodipine on steady-state digoxin concentrations and renal digoxin clearance.
Schwartz JB
J Cardiovasc Pharmacol; 1988 Jul; 12(1):1-5. PubMed ID: 2459525
[TBL] [Abstract][Full Text] [Related]
20. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes.
Heizer WD; Pittman AW; Hammond JE; Fitch DD; Bustrack JA; Hull JH
DICP; 1989 Oct; 23(10):764-9. PubMed ID: 2815851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
